© 2002 by the American Institute of Ultrasound in Medicine
J Ultrasound Med 21:77-84 0278-4297
Hepatocellular Carcinoma
Contrast Enhancement With Levovist
Byung Ihn Choi, MD,
Ah Young Kim, MD,
Jae Young Lee, MD,
Kyoung Won Kim, MD,
Kyoung Ho Lee, MD,
Tae Kyoung Kim, MD and
Joon Koo Han, MD
Department of Radiology and Institute of Radiation Medicine, Seoul National University College of Medicine, and Clinical Research Institute, Seoul National University Hospital (B.I.C., K.W.K., K.H.L., J.K.H.), Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine (A.Y.K., T.K.K.), and Department of Radiology, Hallym University Hospital (J.Y.L.), Seoul, Korea
Address correspondence and reprint requests to Byung Ihn Choi, MD, Department of Radiology, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Korea.
Objective. To present the sonographic appearance of hepatocellular carcinoma imaged with the intravenous contrast agent Levovist. Methods. We reviewed our experience using Levovist (Schering AG, Berlin, Germany) for the sonographic diagnosis of hepatocellular carcinoma. Results. Contrast-enhanced sonography with Levovist facilitated detailed evaluation of tumor vascularity in hepatocellular carcinoma. Conclusions. Contrast-enhanced sonography with Levovist enhances the role of sonography in the diagnosis of hepatocellular carcinoma. It provides detailed information about tumor vascularity and the contrast enhancement pattern.
Key Words: hepatocellular carcinoma tumor vascularity Doppler sonography sonographic contrast agents Abbreviations: ADI, agent detection imaging AFP, -fetoprotein HBsAg, hepatitis B surface antigen CD, color Doppler CHI, coded harmonic imaging CT, computed tomography HCC, hepatocellular carcinoma PD, power Doppler
This article has been cited by other articles:

|
 |

|
 |
 
S. R. Wilson and P. N. Burns
An Algorithm for the Diagnosis of Focal Liver Masses Using Microbubble Contrast-Enhanced Pulse-Inversion Sonography.
Am. J. Roentgenol.,
May 1, 2006;
186(5):
1401 - 1412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Giorgio, G. Ferraioli, L. Tarantino, G. de Stefano, V. Scala, F. Scarano, C. Coppola, and L. Del Viscovo
Contrast-Enhanced Sonographic Appearance of Hepatocellular Carcinoma in Patients with Cirrhosis: Comparison with Contrast-Enhanced Helical CT Appearance
Am. J. Roentgenol.,
November 1, 2004;
183(5):
1319 - 1326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W. Kim, B. I. Choi, S. H. Park, H.-C. Kim, M. W. Lee, S. H. Kim, K. H. Lee, C. H. Park, J. S. Kim, H.-J. Won, et al.
Hepatocellular Carcinoma: Assessment of Vascularity With Single-Level Dynamic Ultrasonography During the Arterial Phase
J. Ultrasound Med.,
September 1, 2003;
22(9):
887 - 896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Youk, J. M. Lee, and C. S. Kim
Therapeutic Response Evaluation of Malignant Hepatic Masses Treated by Interventional Procedures With Contrast-Enhanced Agent Detection Imaging
J. Ultrasound Med.,
September 1, 2003;
22(9):
911 - 920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nagase, J. Furuse, H. Ishii, and M. Yoshino
Evaluation of Contrast Enhancement Patterns in Pancreatic Tumors by Coded Harmonic Sonographic Imaging With a Microbubble Contrast Agent
J. Ultrasound Med.,
August 1, 2003;
22(8):
789 - 795.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|